Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,66
KB0,17
PKN129,28129,3-0,28
Msft415,07415,090,94
Nokia8,5268,534-0,14
IBM246,72246,90,82
Mercedes-Benz Group AG53,4853,49-1,78
PFE27,2427,250,20
16.04.2026 16:39:01
Indexy online
AD Index online
select
AD Index online
 

  • 30.03.2026 17:02:08
Solvay SA (SOLB.F, Frankfurt)
Poslední obchod Změna (%) Změna (EUR) Objem obchodů (EUR)
26,70 -0,37 -0,10 668
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 16.04.2026
Popis společnosti

Business Summary: Solvay SA is a Belgium-based company. The Company is predominantly engaged and focuses on providing chemical products and intermediates. It principally presents its services to customers in a broad range of consumer and industrial end-markets. Its portfolio concentrates on operating through five main divisions: Soda Ash and Derivatives, Peroxides, Silica, Special Chem and Coatis. It offers customer-proximate regional locations as well as competitive cost curve positioning due to the vertical integration in its main businesses, process technology and product know-how. It mainly has a balanced global footprint with 12 R&I centers' as well as 45 industrial sites in 41 countries across the world.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Solvay SA revenues decreased 7% to EUR4.75B. Net income decreased 87% to EUR30M. Revenues reflect Basic Chemicals Soda Ash & Derivatives segment decrease of 10% to EUR1.71B, Performance Chemicals segment decrease of 26% to EUR470M, Brazil segment decrease of 19% to EUR477M, United States segment decrease of 11% to EUR750M.



  • Poslední aktualizace: 16.04.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerRobert Davis5801.12.202223.04.2014
Chief Financial Officer, Executive Vice PresidentCaroline Litchfield5601.04.2021
Chief Human Resources Officer, Executive Vice PresidentBetty Larson4901.04.202401.04.2024
Executive Vice President, Chief Information and Digital OfficerDavid Williams56
Executive Vice President, General CounselJennifer Zachary4716.04.2018
Executive Vice President and President - Merck Manufacturing DivisionSanat Chattopadhyay65
Executive Vice President, President - Merck Animal HealthRichard Deluca6215.09.201115.09.2011
Executive Vice President, Chief Communications and Public Affairs OfficerCristal Downing5616.08.202116.08.2021
Executive Vice President, President - Specialty, Pharma & Infectious DiseasesBrian Foard5202.03.202602.03.2026
Executive Vice President - Strategic Access, Policy & CommunicationsChirfi Guindo5923.02.2026